BODIPY compounds, preparation methods and uses thereof as photosensitizers
By introducing a specific structure into the BODIPY molecule and designing a near-infrared pure type I photosensitizer with high reactive oxygen production, the problem of insufficient reactive oxygen production in existing BODIPY dimer photosensitizers was solved, achieving a more efficient photodynamic therapy effect.
Patent Information
- Application Number
- CN202510316997.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2025-03-18
- Publication Date
- 2025-09-16
- Estimated Expiration
- 2045-03-18
AI Technical Summary
The existing BODIPY dimer photosensitizer molecules have insufficient ability to generate reactive oxygen species and are unable to meet the needs of efficient photodynamic therapy.
By introducing heavy atoms and 2,4,6-trimethylphenyl groups at specific positions in the BODIPY molecular structure, a near-infrared pure type-I photosensitizer with high reactive oxygen production rate was designed and constructed, and the excited state energy level was regulated to increase the ISC rate and triplet lifetime of the photosensitizer.
The active oxygen production rate is significantly improved, which is 50 times that of the common photosensitizer indocyanine green. It has higher photothermal stability and photodynamic therapy effect, and the preparation method is simple and efficient.